Twenty-Five Years of Progress in Cancer - Takeaways - MDSpire

Twenty-Five Years of Progress in Cancer

As we close out the first quarter of the twenty-first century, it isn’t hard to notice how much the world has changed since the year 2000. Smartphones. Social media. Artificial intelligence.  

  • By

  • December 17, 2025

  • 8 min

Share

  • 1

    Since 2000, cancer treatment has expanded significantly, introducing eleven new therapy types approved by the FDA.

  • 2

    Dana-Farber has played a key role in developing new cancer drugs, including those approved in 2025 for various cancer types.

  • 3

    Research at Dana-Farber focuses on innovative therapies, such as NK cell therapies and personalized cancer vaccines, currently in clinical trials.

  • 4

    Clinical trials are underway for RAS-targeted therapies in pancreatic cancer and antibody-drug conjugates for triple-negative breast cancer.

  • 5

    Advancements in combination therapies are showing promise in improving outcomes for patients with lung cancer and other malignancies.

Original Source(s)

Twenty-Five Years of Progress in Cancer

  • by

  • December 17, 2025

Related Content

Characteristics and risk factors of immune-related adverse events in patients receiving immune checkpoint inhibitor combination therapy

Bilateral renal metastasis following radical prostatectomy for prostate cancer: a case report

Artificial intelligence for optimization of immunotherapy: current applications and transformative potential